Clinical Trial: Super-Resolution Ultrasound Imaging for Assessing Response to Neoadjuvant Chemotherapy in Breast Cancer

U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623226) titled 'Super-Resolution Ultrasound Imaging for Assessing Response to Neoadjuvant Chemotherapy in Breast Cancer' on May 07.

Brief Summary: 1. Study Design Overview Study Type: Single-center, prospective, observational, diagnostic study. Primary Objective: To validate whether Super-Resolution Ultrasound Imaging (SRUS) can accurately predict pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer at an early stage (after the first cycle of chemotherapy).

Sample Size: A total of 150 patients are planned to be enrolled. Study Period: March 2026 - March 2028.

2. Core Methodology: Cohort Allocation This study empl...